These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 453784)
1. Estradiol receptor assays in normal and neoplastic tissues. A possible diagnostic acid for tumor differentiation. Molteni A; Bahu RM; Battifora HA; Fors EM; Reddy JK; Rao MS; Scarpelli DG Ann Clin Lab Sci; 1979; 9(2):103-8. PubMed ID: 453784 [TBL] [Abstract][Full Text] [Related]
2. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Zhang H; Stephens LC; Kumar R Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771 [TBL] [Abstract][Full Text] [Related]
3. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen. Morrissey JJ; Raney S Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849 [TBL] [Abstract][Full Text] [Related]
4. Binding characteristics and biological activity of 17 alpha-[125I]iodovinyl-11 beta-methoxyestradiol, an estrogen receptor-binding radiopharmaceutical, in human breast cancer cells (MCF-7). McManaway ME; Jagoda EM; Eckelman WC; Larson SM; Francis BE; Gibson RE; Reba RC; Lippman ME Cancer Res; 1986 May; 46(5):2386-9. PubMed ID: 3697981 [TBL] [Abstract][Full Text] [Related]
5. Binding analysis of the estrogen receptor to its specific DNA target site in human breast cancer. Foster BD; Cavener DR; Parl FF Cancer Res; 1991 Jul; 51(13):3405-10. PubMed ID: 2054780 [TBL] [Abstract][Full Text] [Related]
6. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells. Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629 [TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis of 1,2,3-Trichloropropane (CAS No. 96-18-4) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Aug; 384():1-348. PubMed ID: 12692652 [TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes. Harrell JC; Dye WW; Allred DC; Jedlicka P; Spoelstra NS; Sartorius CA; Horwitz KB Cancer Res; 2006 Sep; 66(18):9308-15. PubMed ID: 16982776 [TBL] [Abstract][Full Text] [Related]
9. Hormonal control of growth and progression in tumors of Nb rats and a theory of action. Noble RL Cancer Res; 1977 Jan; 37(1):82-94. PubMed ID: 830424 [TBL] [Abstract][Full Text] [Related]
10. [Studies on specific markers of hormone-dependence in endometrial carcinoma : estradiol receptors and uterine peroxidase (author's transl)]. Morikawa S; Sekiya S; Takamizawa H Acta Obstet Gynaecol Jpn; 1981 Mar; 33(3):339-43. PubMed ID: 7211223 [TBL] [Abstract][Full Text] [Related]
11. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis. Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976 [TBL] [Abstract][Full Text] [Related]
12. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice. Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929 [TBL] [Abstract][Full Text] [Related]
13. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells. Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074 [TBL] [Abstract][Full Text] [Related]
14. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?]. Rochefort H C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098 [TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463 [TBL] [Abstract][Full Text] [Related]
16. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas. Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613 [TBL] [Abstract][Full Text] [Related]
18. [Multi-component system of estrogen binding proteins from the liver: characterization of binding properties of high molecular weight protein from rat liver similar to uterine estradiol receptors]. Mataradze GD; Rukaĭia MKh; Smirnov AN; Rozen VB Biokhimiia; 1979 Aug; 44(8):1484-92. PubMed ID: 497294 [TBL] [Abstract][Full Text] [Related]
19. 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer. Jansson AK; Gunnarsson C; Cohen M; Sivik T; Stål O Cancer Res; 2006 Dec; 66(23):11471-7. PubMed ID: 17145895 [TBL] [Abstract][Full Text] [Related]
20. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors. Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]